Advertisement
Screener

BOSTON SCIENTIFIC CORPORATION (BSX) Material Contracts, 2023

BOSTON SCIENTIFIC CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2023-11-22: Form 8-K; Exhibit 10.3; Description Boston Scientific Corporation 2024 Organic Net Sales Performance Share Program.
  • 2023-11-22: Form 8-K; Exhibit 10.2; Description Boston Scientific Corporation 2024 Relative Total Shareholder Return Performance Share Program.
  • 2023-11-22: Form 8-K; Exhibit 10.1; Description Boston Scientific Corporation 2024 Annual Bonus Plan, effective as of January 1, 2024.
  • 2023-06-27: Form 8-K; Exhibit 10.1; Description Press Release issued by Boston Scientific Corporation, dated June 27, 2023..
FiledFormExhibitDescription
2023-11-228-K10.3Boston Scientific Corporation 2024 Organic Net Sales Performance Share Program
2023-11-228-K10.2Boston Scientific Corporation 2024 Relative Total Shareholder Return Performance Share Program
2023-11-228-K10.1Boston Scientific Corporation 2024 Annual Bonus Plan, effective as of January 1, 2024
2023-06-278-K10.1Press Release issued by Boston Scientific Corporation, dated June 27, 2023.
2023-05-0410-Q10.5Form of 2023 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Organic Net Sales Growth). #
2023-05-0410-Q10.4Form of 2023 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return). #
2023-05-0410-Q10.3Form of 2023 Global Restricted Stock Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-05-0410-Q10.2Form of 2023 Global Non-Qualified Stock Option Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-03-018-K10.1Second Amendment, dated as of March 1, 2023, to Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent.
2023-02-2310-K10.85Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as amended and restated, effective January 1, 2023. #
2023-02-2310-K10.84Form of Offer Letter by and between the Company and Jeffrey Mirviss, dated December 11, 2012. #
2023-02-2310-K10.83Form of Offer Letter by and between the Company and Arthur Butcher, dated April 1, 2022. #
2023-02-2310-K10.81Form of 2022 Restricted Stock Unit Award Agreement for Non-Employee Directors under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.80Form of 2022 Restricted Stock Award Agreement for Non-Employee Directors under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.79Form of 2022 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Free Cash Flow). #
2023-02-2310-K10.78Form of 2022 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return). #
2023-02-2310-K10.77Form of 2022 Global Restricted Stock Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.76Form of 2022 Global Non-Qualified Stock Option Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.72Amendment, dated as of December 21, 2022, to Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the several lenders parties thereto, Barclays Bank PLC, Citibank, N.A., Deutsche Bank Securities Inc., Goldman Sachs Bank USA, and JPMorgan Chase Bank, N.A as documentation agents, and Wells Fargo Bank, National Association, as administrative agent.
2023-02-2310-K10.70Form of 2021 Restricted Stock Unit Award Agreement for Non-Employee Directors under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.69Form of 2021 Restricted Stock Award Agreement for Non-Employee Directors under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.68Form of 2021 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Free Cash Flow). #
2023-02-2310-K10.67Form of 2021 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return). #
2023-02-2310-K10.66Form of 2021 Global Restricted Stock Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.65Form of 2021 Global Non-Qualified Stock Option Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.58Form of 2020 Deferred Stock Unit Award Agreement for Non-Employee Directors under the Company's 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.57Form of 2020 Restricted Stock Award Agreement for Non-Employee Directors under the Company's 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.56Form of 2020 Global Restricted Stock Unit Award Agreement under the Company's 2011 Long-Term Incentive Plan. #
2023-02-2310-K10.55Form of 2020 Global Non-Qualified Stock Option Agreement under the Company's 2011 Long-Term Incentive Plan. #

Similar stocks

Stock NameCountryMarket CapPE Ratio
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
3M CO (MMM)United States$86.404B27.87
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
STRYKER CORP (SYK)United States$103.511B32.39
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12